{{Drugbox
| verifiedrevid = 
| IUPAC_name = 2-amino-1-(4-methylphenyl)propan-1-one
| image = 4-Methylcathinone.png
| width = 220
| image2 = 4-MethylCathinone.png

<!--Clinical data-->
| tradename =  
| legal_CA = Schedule I
| legal_UK = Class B
| legal_status =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 31952-47-3
| CAS_number2 = 6941-17-9
| index_label =
| index2_label = HCl
| DrugBank_Ref = 
| PubChem = 414532
| ChemSpiderID = 367058
| UNII = CY9HK59OK6

<!--Chemical data-->
| C=10 | H=13 | N=1 | O=1 
| molecular_weight = 163.219 g/mol
|  smiles = CC1=CC=C(C=C1)C(=O)C(C)N
|  StdInChI = 1S/C10H13NO/c1-7-3-5-9(6-4-7)10(12)8(2)11/h3-6,8H,11H2,1-2H3
|  StdInChIKey = OHULHWHSUJEYIT-UHFFFAOYSA-N
}}

'''4-Methylcathinone''' (also known as '''Nor-Mephedrone''', '''4-MC''' and '''NSC-60487'''), is a [[stimulant]] [[drug]] of the [[substituted cathinone|cathinone]] [[chemical class]] that has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/9000940 | title=nor-Mephedrone | publisher=Cayman Chemical | accessdate=27 June 2015}}</ref> It is a metabolite of the better known drug [[mephedrone]] (4-methylmethcathinone).<ref>{{cite journal | url=https://link.springer.com/article/10.1007%2Fs00216-010-3636-5 | title=Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry | author=Markus R. Meyer | author2=Jens Wilhelm | author3=Frank T. Peters| author4=Hans H. Maurer | journal=Analytical and Bioanalytical Chemistry |date=June 2010  | volume=397 | issue=3 | pages=1225–1233 | doi=10.1007/s00216-010-3636-5 | pmid=20333362}}</ref><ref>{{cite journal | url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1369/abstract | title=In vitro metabolism studies on mephedrone and analysis of forensic cases | date=June 2013 | author=Anders Just Pedersen | author2=Lotte Ask Reitzel | author3=Sys Stybe Johansen | author4=Kristian Linnet | journal=Drug Testing and Analysis | volume=5 | issue=6 | pages=430–438 | doi=10.1002/dta.1369 | pmid=22573603}}</ref><ref>{{cite journal | url=http://onlinelibrary.wiley.com/doi/10.1002/dta.312/abstract | title=The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone) | date=July–August 2011 | author=Paul I. Dargan | author2=Roumen Sedefov | author3=Ana Gallegos | author4=Dr David M. Wood | journal=Drug Testing and Analysis | volume=3 | issue=7–8 | pages=454–463 | doi=10.1002/dta.312 | pmid=21755604}}</ref>

4-Methylcathinone displays a 2.4-fold selectivity to promote [[monoamine releasing agent|monoamine release]] via [[Dopamine transporter|DAT]] over [[Serotonin transporter|SERT]] as opposed to 309-fold selectivity for [[cathinone]].<ref>{{cite journal | url=http://www.sciencedirect.com/science/article/pii/S0924977X15003934 | title=Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats | date=February 2016 | author=Blake A. Hutsell | author2=Michael H. Baumann | author3=John S. Partilla | author4=Matthew L. Banks | author5=Rakesh Vekariya | author6=Richard A. Glennon | author7=S. Stevens Negus | journal=European Neuropsychopharmacology | volume=26 | issue=2 | pages=288–297 | doi=10.1016/j.euroneuro.2015.12.010 | pmid=26738428}}</ref>

== See also ==
* [[4-Methylbuphedrone]]
* [[4-Methylethcathinone]]

== References ==
{{Reflist|2}}

{{Stimulants}}
{{Phenethylamines}}
{{Entactogens}}

{{DEFAULTSORT:Methylcathinone, 4-}}
[[Category:Cathinones]]
[[Category:Designer drugs]]
[[Category:Serotonin-dopamine releasing agents]]


{{nervous-system-drug-stub}}